QUINOLINE DERIVATIVES AS NK-2 AND NK-3 RECEPTOR ANTAGONISTS

Title:

QUINOLINE DERIVATIVES AS NK-2 AND NK-3 RECEPTOR ANTAGONISTS

Document Type and Number:

WIPO Patent Application WO2004066951

Kind Code:

A3

Abstract:

Compounds of the formula (I) are disclosed which are NK2 and NK3 receptor antagonists and are useful in the treatment of respiratory diseases: or a pharmaceutically acceptable salt thereof.

Inventors:

KERNS JEFFREY (US)
JIN QI (US)
YAN HONGXING (US)
WAN ZEHONG (US)

Application Number:

PCT/US2004/002425

Publication Date:

December 29, 2004

Filing Date:

January 29, 2004

Export Citation:

Click for automatic bibliography generation Help

Assignee:

SMITHKLINE BEECHAM CORP (US)
KERNS JEFFREY (US)
JIN QI (US)
YAN HONGXING (US)
WAN ZEHONG (US)

International Classes:

A61K31/496; C07D401/06; A61K; (IPC1-7): A61K31/496; C07D401/06

Domestic Patent References:

WO2002044165A1

2002-06-06

Download PDF:

View/Download PDF PDF Help

Previous Patent: QUINOLINE DERIVATIVES AS NK-2 AND NK-3 RECEPTOR ANTAGONISTS

Next Patent: BENZOXAZOLE, BENZOTHIAZOLE, AND BENZIMIDAZOLE DERIVATIVES FOR THE TREATMENT OF CANCER AND OTHER DISE...